Table 1.
Clinical characteristics of 31 migraine status patients and comparison thereof between the two therapeutic groups
| Clinical characteristic /Therapeutic group |
IVVP Orifil
N=19 |
IV DEX
N=12 |
Statistical analysis |
|---|---|---|---|
| mean ± SD | mean ± SD | ||
| Mean age* | 33.895±13.337 | 32.500±11.188 | t=-0.361, df=29, P=0.766 |
| Mean migraine history ** | 6.263±8.993 | 6.000±8.068 | t=-0.082, df=29, P=0.935 |
| Presence of aura | 38.84% | 8.34% | P=0.077 |
| Recovery from nausea | 68.42% | 91.67 | P=0.201 |
| Recovery from photophobia | 78.95% | 91.67% | P=0.624 |
| Pain-free response after treatment | 26.32% | 33.33% | P=0.704 |
*Per year; **Per month; IVVP: intravenous Valproate; IVDEX: intravenous Dexamethasone; The t test was used for mean age and mean migraine history, and the Fisher test served for comparing the items in the four lower rows.